Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2000 | Regulation of adenylyl cyclase in the central nervous system | Chern, Y. | Cell Signal 12, 195-204 | | | |
1995 | Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A | Chern, Y.; Chiou, J. Y.; Lai, H. L.; Tsai, M. H. | Mol Pharmacol 48, 1-8 | | | |
2007 | Regulation of type V adenylyl cyclase by Ric8a, a guanine nucleotide exchange factor | Wang, S. C.; Lai, H. L.; Chiu, Y. T.; Ou, R.; Huang, C. L.; Chern, Y. | Biochem J 406(3), 383-388 | | | |
2004 | Regulation of type VI adenylyl cyclase by Snapin, a SNAP25 interacting protein. | Chou, J-l; Huang, C-L; Lai, H-L; Hong, A. C.; Chien, C-L; Kao, Y-Y; Chern, Y. | J. Biol. Chem. 279, 46271-46279 | | | |
2006 | Rescue of p53 blockage by the A2A adenosine receptor via a novel interacting protein, Translin-associated protein X | Sun, C. N.; Cheng, H. C.; Chou, J. L.; Lee, S. Y.; Lin, Y. W.; Lai, H. L.; Chen, H. M.; Chern, Y. | Mol Pharmacol 70(2), 454-466 | | | |
1991 | Structural role of amino acids 99-110 recombinant human erythropoietin | Chern, Y.; Chung, T.; Sytkowski, A. J. | Eur J Biochem 202, 225-229 | | | |
2007 | Systematic uncovering of multiple pathways underlying the pathology of Huntington's disease by an acid-cleavable isotope-coded affinity tag approach | Chiang, M. C.; Juo, C. G.; Chang, H. H.; Chen, H. M.; Yi, E. C.; Chern, Y. | Mol Cell Proteomics 6, 781-797 | | | |
1999 | The 5' untranslated regions of the rat A2A adenosine receptor gene function as negative translational regulators | Lee, Y. C.; Chang, C. W.; Su, C. W.; Lin, T. N.; Sun, S. H.; Lai, H. L.; Chern, Y. | J Neurochem 73, 1790-1798 | | | |
1999 | The N terminus domain of type VI adenylyl cyclase mediates its inhibition by protein kinase C | Lai, H. L.; Lin, T. H.; Kao, Y. Y.; Lin, W. J.; Hwang, M. J.; Chern, Y. | Mol Pharmacol 56, 644-650 | | | |